Methods and agents for improving targeting of CD138 expressing tumor cells
Details for Australian Patent Application No. 2008339913 (hide)
International Classifications
Event Publications
15 July 2010 PCT application entered the National Phase
PCT publication WO2009/080832 Priority application(s): WO2009/080832
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008339917-Macrocyclic indoles as hepatitis C virus inhibitors
2008339911-Immunoconjugates targeting CD138 and uses thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser